FAPI Newsletter Q1 – 2026
A WORD FROM OUR CHIEF SCIENTIFIC OFFICER
Dear FAPI […]
Ensuring enantiomeric consistency in FAPI radiopharmaceuticals: comparative analysis of (S)- and (S/R)-FAPI-46/-74 confirms pharmacological equivalence GalleryEnsuring enantiomeric consistency in FAPI radiopharmaceuticals: comparative analysis of (S)- and (S/R)-FAPI-46/-74 confirms pharmacological equivalence
Ensuring enantiomeric consistency in FAPI radiopharmaceuticals: comparative analysis of (S)- and (S/R)-FAPI-46/-74 confirms pharmacological equivalence
Magdalena Staniszewska, Ralph Hübner, Camilla Locatelli, Douglas Howard, Matilde Forni, Francis Man, Bent Wilhelm Schoultz, […]
90Y-FAPI-46 Radiopharmaceutical Therapy in Sarcoma and Other Solid Tumors: An Updated Cohort Analysis
Helena Lanzafame, Ilektra A. Mavroeidi, Kim M. Pabst, Pedro Fragoso Costa, Martin Schuler, Sebastian Bauer, […]
Revealing Reliability and Practicability of FAP-RADS Version 1.0 for Structured Reporting of FAPI Imaging in Pulmonary and Urothelial Carcinoma
Emil Novruzov, Eduards Mamlins, Liam Widjaja, Sophie C Siegmund, Tadashi Watabe, Yuriko Mori, Christian Stief, […]
![Addressing Unmet Needs with [18F]FAPI-74](https://sofie.com/wp-content/uploads/2026/02/FAPI.jpg)
Addressing Unmet Needs with [18F]FAPI-74
Presented by: Sherly Mosessian, PhD, Chief Scientific Officer, SOFIE
8th Theranostics World Congress; Cape Town, South […]
SOFIE’s Phase 2 FAPI Study Outcomes Showcased at ASCO GI 2026
Results from SOFIE’s Phase 2 diagnostic study on [18F]FAPI-74 PET were presented to the oncological […]
Focus on FAPI Newsletter – Q4 2025
A WORD FROM OUR CHIEF SCIENTIFIC OFFICER
Dear FAPI […]
Mosessian Named one of Top 25 Women Chief Scientific Officers in 2025
Sherly Mosessian, PhD, SOFIE’s Chief Scientific Officer, has been recognized by the […]
![FAP Expression in Renal Tumors Assessed by [68Ga]Ga-FAPI-46 PET Imaging and FAP Immunohistochemistry: A Case Series of Six Patients from the Prospective Exploratory Trial NCT04147494](https://sofie.com/wp-content/uploads/2025/12/info.ibamolecular-scaled.jpg)
FAP Expression in Renal Tumors Assessed by [68Ga]Ga-FAPI-46 PET Imaging and FAP Immunohistochemistry: A Case Series of Six Patients
Adrien Holzgreve, Lena M Unterrainer, Kimberly Flores, Ethan C Lam, Christine E Mona, Johannes Czernin, […]
68Ga-FAPI PET/CT Prevents Futile Surgery and Demonstrates Tumor Biology in Patients with Pancreatic Ductal Adenocarcinoma
William McGahan, Alexa Chadwick, Karen Lindsay, Brook Gulhane, Melissa J Latter, Thomas O’Rourke, Paul A […]